Phase 3 Lung Adenocarcinoma Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
Lung AdenocarcinomaCryotherapy Effect
Institut Bergonié214 enrolled1 locationNCT04339218
Recruiting
Phase 3
Segmentectomy for Solid-dominant Lung Cancer
Lung AdenocarcinomaSegmentectomy
Fudan University277 enrolled1 locationNCT06634966
Recruiting
Phase 3
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
Lung AdenocarcinomaSegmentectomy
Fudan University307 enrolled1 locationNCT05717803
Recruiting
Phase 3
Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
Lung AdenocarcinomaFrozen SectionSublobar Resection
Fudan University390 enrolled1 locationNCT06031181
Recruiting
Phase 3
Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)
Lymph Node MetastasisLung Adenocarcinoma
Fudan University634 enrolled1 locationNCT06031246